Since launching Antheia in 2015, we’ve made tremendous strides toward our mission to transform pharmaceutical supply chains for essential medicines. We’ve strengthened our leadership team with veteran executives across R&D, operations, supply chain, and quality and regulatory, we’ve repeatedly validated our technology at commercially-relevant scales, and we are now actively moving into full-scale production to bring our products to market.
To keep pace with the company’s evolution, we’re excited to announce the launch of our refreshed brand identity – and newly redesigned website – that better represents who Antheia is today.
As a company that sits at the intersection of synthetic biology and pharma, our digital presence now reflects the unique and critical role that we believe synthetic biology will play in pharma, as well as our unwavering commitment to building resilient pharmaceutical supply chains that can support the growing demands of modern healthcare.
While we’re still the same Antheia, we’re incredibly proud to introduce our reinvigorated brand and hope you’ll feel as inspired as we do. A special thanks to all of our team of colleagues, partners, and steadfast supporters for being on this journey with us.